COVID research leads to breakthroughs for chronic disease, cancer

Billions of dollars invested in mRNA vaccines and COVID research could yield health care dividends for decades to come.

Related Keywords

Oklahoma ,United States ,Boston ,Massachusetts ,Pennsylvania ,Americans ,Nicholas Kelly ,Liz Szabo ,Michelle Monje ,Judith James ,David Lockhart ,Emily Taylor ,Michael Klompas ,E John Wherry ,Lauren Nichols ,Avindra Nath ,David Systrom ,Gary Michelson ,University Of Alabama ,University Of Pennsylvania Institute For Immunology ,Emory University School Of Medicine ,Cystic Fibrosis Foundation ,Pfizer ,Oklahoma Medical Research Foundation ,Kaiser Health News ,Rockefeller University ,National Institute Of Neurological Disorders ,Centers For Disease ,Vertex Pharmaceuticals ,National Institutes Of Health ,World Health Organization ,Harvard Medical School ,Fatigue Laboratory ,Stanford University ,Kaiser Health ,Oklahoma Medical Research ,Recode Therapeutics ,Arcturus Therapeutics ,Cystic Fibrosis ,Carlos Del Rio ,Emory University School ,Paul Bastard ,Michelson Philanthropies ,Disease Control ,National Institute ,Neurological Disorders ,National Institutes ,Jarred Younger ,Body Politic ,Enhance Recovery ,